Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
about
Polychromatic flow cytometry in evaluating rheumatic disease patientsBack to the future: oral targeted therapy for RA and other autoimmune diseases.B-cell selection and the development of autoantibodies.Phosphorothioate-modified CpG oligodeoxynucleotides mimic autoantigens and reveal a potential role for Toll-like receptor 9 in receptor revision.Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.SYK expression level distinguishes control from BRCA1-mutated lymphocytes.
P2860
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
@en
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
@nl
type
label
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
@en
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
@nl
prefLabel
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
@en
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
@nl
P2093
P2860
P1433
P1476
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
@en
P2093
Alexander F Rosenberg
Chungwen Wei
Iñaki Sanz
James Roger
Jennifer L Kelly
Jonathan W Friedberg
Julia Schaefer-Cutillo
P2860
P304
P356
10.1016/J.CLIM.2011.12.012
P50
P577
2012-01-05T00:00:00Z